Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 20-F (Mark One) ? REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR ? ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934...
Annual Report filed on Form 20-F
Filed with ASX ·
6ix hasn’t read this filing yet.
Earlier from Immutep
- Quality of Life Data from EFTISARC-NEO presented at ESMO
- Late-Breaking Abstract on IMP761 to be presented at ACR 2026
- 2026 Annual General Meeting and Key Dates
- Immutep & Monash Secure Further ARC Funding for LAG-3
- Immutep Regains Compliance with Nasdaq
Later from Immutep
- Annual Report to shareholders
- Appendix 4G and Corporate Governance Statement
- Notice of Annual General Meeting/Proxy Form
- Immutep Receives A$2.16 million French R&D Tax Incentive
- Immutep Quarterly Activities Report and Appendix 4C
